Home > Investor Info > Investor Relations  

 

Investor Relations

 

 

Osmetech plc Ticker: OMH Exchanges: LON
   
For up to date information on share price visit the London Stock Exchange landMARK web site
Trade mark of London Stock Exchange plc
     
 

Contact Osmetech Investor Relations: InvestorRelations@osmetech.com

 

Corporate Information

 

COMMITTEES OF THE BOARD OF DIRECTORS

 

Remuneration Committee

The Board operates a Remuneration Committee, which is responsible for the monitoring and review of the remuneration of the executive directors. The members of the committee are Chris Gleeson and Daryl Faulkner.

 

Audit Committee

The Audit Committee is responsible for monitoring the adequacy of the Group’s internal financial controls, accounting policies and financial reporting. The members of the committee are Chris Gleeson and Daryl Faulkner.

 

SHAREHOLDER PROFILE

 

The following information was last updated on 19 March 2010.

 

• Total Issued Ordinary Share Capital – 1,637,011,420 Ordinary Shares of 0.10p each


• 41.71 % of shares are not in public hands


• Significant Shareholders are:

 

Person Interested

Number of Osmetech Shares

Percentage of total voting rights in Osmetech
Gartmore 304,580,846 18.6
Efficacy Biotech Master Fund 201,915,914 12.3
Fidelity 147,133,039 9.0
Schroders 142,974,873 8.7
John Stafford III & Ronin Trading U.K. LLP 120,964,287 7.4
Jon Faiz Kayyem

116,355,087

7.1
Christopher Gleeson 59,895,835 3.7
LaunchEquity Acquisition Partners LLC 59,895,835 3.6
Jeffrey Taylor 55,819,243 3.4
Bradshaw Asset Management 49,538,148 3.0
     

 

ARTICLES OF ASSOCIATION

 

The Osmetech plc Articles of Association can be viewed in PDF format with Adobe Acrobat.

Please click to access the >> Articles of Association

 

AIM ADMISSION DOCUMENT AND CIRCULARS

 

The following documents can be viewed in PDF format with Adobe Acrobat.

Please click to access the >> Placing and Offer Prospectus.pdf

 

Please click to access the >> Circular 18 December 2006.pdf

 

The Company has been made aware that some shareholders have received unsolicited phone calls or correspondence concerning offers for their shareholdings in Osmetech. Please click here for more information.